SOMAZINA

This brand name is authorized in Ecuador, Hong Kong SAR China, Malta, Mexico, Spain.

Active ingredients

The drug SOMAZINA contains one active pharmaceutical ingredient (API):

1	Citicoline UNII 536BQ2JVC7 - CITICOLINE
	Citicoline stimulates the biosynthesis of structural phospholipids of the neuronal membrane. Citicoline, through this action, improves the function of the membrane mechanisms, such as the functioning of the ionic exchange pumps and receptors inserted in the latter, the modulation of which is indispensable in the neurotransmission.
	Read more about Citicoline

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
SOMAZINA Oral solution	MPI, EU: SmPC	Medicines Authority (MT)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N06BX06	Citicoline	N Nervous system → N06 Psychoanaleptics → N06B Psychostimulants, agents used for ADHD and nootropics → N06BX Other psychostimulants and nootropics
Discover more medicines within N06BX06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	17.375-2-04-04, 17.378-2-05-03, 17.379-2-04-03, 27.266-09-06, 28910-06-09
ES	Centro de información online de medicamentos de la AEMPS	53168, 54389, 54390, 69416
HK	Department of Health Drug Office	65122
MT	Medicines Authority	MA130/00201
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	344M2003, 508M2003